Abstract
At the annual meeting of the Danish Surgical Society in December 1975, a task force was set up to nationally coordinate the new principles of systemic therapy of breast cancer. Over the following 2 years the structure of the Danish Breast Cancer Cooperative Group (DBCG) was organized and in 1977 the first clinical program, DBCG-77, was activated [1, 8]. This paper will briefly review the present status of this program.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andersen KW, Mouridsen HT, Castberg T, Fischerman K, Andersen J, Hou-Jensen K, Brincker H, Johansen H, Henriksen E, Rórth M, Rossing N, DBCG (1981) Organization of the Danish Adjuvant Trials in Breast Cancer. Dan Med Bull 28: 102–106
Baum N, other members of the Nolvadex Adjuvant Trial Organization (1983) Control trial of Tamoxifen as adjuvant agent in management of early breast cancer. Lancet 1: 257–261
Brincker H, Mouridsen HT, Andersen KW, Andersen J, Castberg T, Fischerman K, Henriksen E, Hou-Jensen K, Johansen H, Rossing N, Rorth M, DBCG (1980) Increased breast-cancer recurrence rate after adjuvant therapy with levamisole. Lancet 2: 824–827
Brincker H, Mouridsen HT, Andersen KW (1983) Adjuvant chemotherapy with cyclophosphamide or CMF in pre-menopausal women with stage II breast cancer. Breast Cancer Res Treat 3: 91–95
Cady B (1973) Total mastectomy and partial axillary dissection. Surg Clin North Am 53: 313–317
Danish Breast Cancer Cooperative Group (1983) Informationsblad no 11
EORTC Breast Cancer Cooperative Group (1980) Revision of standards for the assessment of hormone receptor in human breast cancer. Report of the second EORTC workshop. Eur J Cancer 16: 1513–1515
Fischerman K, Mouridsen HT (1977) Danish Breast Cancer Cooperative Group — DBCG. Ugeskr Leger 139: 2493–2494
Koenders A, Thorpe SM (1983) Standardization of steroid receptor-assays in human breast cancer — I: Reproducibility of estradiol-and progesterone-receptorassays. Eur J Cancer Clin Oncol 19: 1221–1229
Mouridsen HT, Palshof T (1983) Adjuvant systemic therapy in breast cancer. A review. Eur J Cancer Clin Oncol 19: 1753–1770
Nissen-Meyer R, Kjellgren K, Mânsson B (1982) Adjuvant chemotherapy in breast cancer. In: Mathé G, Bonadonna G, Salmon S (eds) Adjuvant therapies of cancer. Springer, Berlin Heidelberg New York (Recent results in cancer research, vol 80 )
Palshof T, Mouridsen HT, Daehnfeldt JL (1980) Adjuvant endocrinotherapy of primary operable breast cancer. Report on the Copenhagen Breast Cancer Trials. Eur J Cancer [Suppl] 1: 183–189
Ribeiro G, Palmer MK (1983) Adjuvant tamoxifen for operable carcinoma of breast: report of clinical trial by Christie Hospital and Holt Radium Institute. Br Med J 286: 827–830
Rose C, Thorpe SM, Mouridsen HT, Andersen JA, Brincker H, Andersen KW (1983) Antiestrogen treatment of postmenopausal women with primary high risk breast cancer. Breast Cancer Res Treat 3: 77–84
Scharf RW, Tarloni H (1968) Histological typing of breast tumors. World Health Organization, Geneva
Wallgren A, Ideström K, Glas U, Kaigas M, Theve NO, Wilking N, Nordenskjöld B, Karnström L, Silverswärd C (to be published) Adjuvant tamoxifen treatment in operable breast cancer. N Engl J Med
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Mouridsen, H.T. et al. (1984). Adjuvant Systemic Therapy in High-Risk Breast Cancer: The Danish Breast Cancer Cooperative Group’s Trials of Cyclophosphamide or CMF in Premenopausal and Tamoxifen in Postmenopausal Patients. In: Senn, HJ. (eds) Adjuvant Chemotherapy of Breast Cancer. Recent Results in Cancer Research, vol 96. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82357-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-82357-2_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82359-6
Online ISBN: 978-3-642-82357-2
eBook Packages: Springer Book Archive